La base de datos Biomedical & Life Sciences collection ha creado nuevas series, con nuevas conferencias.

New Series  “Antivirals: Latest Developments and Future Progress”

1. Antivirals versus vaccines – Prof. Albert D.M.E. Osterhaus – Erasmus Medical Centre, The Netherlands

2. Prospects of anti-HIV therapy and prophylaxis – Prof. Dr. Erik De Clercq – Rega Institute for Medical Research, K.U.Leuven, Belgium

3. Antiviral therapy of chronic Hepatitis B virus infections: is resistance still a challenge?- Prof. Fabien Zoulim – Lyon University and INSERM, France

4. Towards the development of potent therapy against the Hepatitis C virus – Prof. Johan Neyts – Rega Institute for Medical Research, K.U.Leuven, Belgium

5. Influenza antivirals: update- Prof. Frederick G. Hayden – University of Virginia School of Medicine, USA

6. Herpes simplex virus and varicella-zoster virus Helicase-Primase inhibitors – Dr. Hugh J. Field – University of Cambridge, UK

7. Nucleoside phosphonates as inhibitors of HIV  – Dr. Tomas Cihlar – Department of Biology, Gilead Sciences, USA

8. HIV-1 integrase inhibitors – Prof. Martin Markowitz – Aaron Diamond Aids Research Center, Rockefeller University, USA

9. Cellular cofactors of HIV integrase: from target identification to discovery of ledgins – Dr. Zeger Debyser – Laboratory for Molecular Virology and Gene Therapy, K.U.Leuven, Belgium
10. HIV entry inhibitors – Prof. José Esté – Universitat Autònoma de Barcelona, Spain

11. Antiviral therapy of orthopoxvirus infection – Prof. Earl R. Kern – University of Alabama, USA/ Prof. Mark N. Prichard – University of Alabama, USA

12. Herpes simplex virus antiviral chemotherapy – Dr. Hugh J. Field – University of Cambridge, UK

13. Cyclophilin inhibitors for HCV – Prof. Robert Flisiak – Medical University of Bialystok, Poland

New Talks Added

Series: Vector-Borne Diseases

The emergence of Lyme disease and other tick-borne diseases – Prof. Durland Fish – Yale University Medical School, USA

Series: Molecular Basis of Bacterial Infection

Vaccines: a health insurance of the 21st Century – Prof. Rino Rappuoli – Novartis Vaccines and Diagnostics, Italy

Series: Non-Clinical Testing for Toxicity of Pharmaceuticals: Regulatory and Practical Standards for Testing and Application

Toxicology of the immune system – Dr. Leigh Ann Burns Naas – Pfizer, USA